Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Breastfeeding While on Ozempic? Patient Asks About Safety and NAD Use

Someone on Reddit asked whether anyone has taken Ozempic while breastfeeding. They said they just reordered a three-month supply and also ordered something called NAD, and they wanted to know if others had experience using Ozempic while nursing. That's the whole prompt — it’s a question from an individual, not a formal study or official guidance. Ozempic is the brand name of a drug whose active ingredient is semaglutide. In plain terms, semaglutide acts a bit like a hormone your gut makes that helps control appetite and blood sugar. People use it to treat type 2 diabetes and, at higher doses under brand names like Wegovy, to help with weight loss. It is given by injection and changes hunger signals and how fast the stomach empties. What this Reddit post shows is anecdotal — one person asking a question, not a clinical trial. There’s no new research here, no systematic data, just someone seeking other people’s experiences. Because it’s a single online question, it can’t tell us how safe Ozempic is during breastfeeding, how often nursing parents take it, or what effects might show up in babies. If you’re looking for evidence, you’d need clinical studies that specifically test drugs in breastfeeding people and their infants; those are limited for many newer medications. Why this matters: many people of childbearing age use medications for diabetes or weight and may breastfeed, so they want to know if continuing a medication is safe for their baby. Decisions about breastfeeding and medications affect both the parent’s health and the infant’s exposure to drug traces. A parent considering Ozempic will care about whether the drug passes into breast milk and whether it could affect the baby’s growth, feeding, or blood sugar. Important caveats: doctors generally caution that we don’t have robust data on semaglutide in breastfeeding. Drug companies often advise against use while nursing because of that lack of data, not necessarily because harm has been proven. Semaglutide is a large molecule and may have limited transfer into milk, but we can’t be sure about effects on infants, especially very young ones. People who are breastfeeding should talk with their healthcare provider before starting or continuing Ozempic. Also, Reddit anecdotes can be incomplete or misleading. If the question includes “NAD” (nicotinamide adenine dinucleotide) supplements, note that over-the-counter “NAD” products vary widely and are not regulated the same way prescription drugs are. Bottom line: this Reddit post is a plea for personal stories, not medical evidence. If you’re breastfeeding and considering Ozempic, discuss it with your clinician to weigh parental needs and infant safety.

Source: r/Semaglutide

Read full story

Back to Riding the pepTIDE